BCEIE › News › PASHUPATI

Bonus issue

Pashupati Cotspin: Board of Directors at its meeting held on October 03, 2026, have considered and approved bonus at the ratio…

Pashupati Cotspin (PASHUPATI) filed a disclosure titled "Board of Directors at its meeting held on October 03, 2026, have considered and approved bonus at the ratio of 236760000 : 157840000, i.e 236760000 Equity Shares for every…". The company is valued at…

BCEIE News Desk · Published 3 Oct 2026, 08:14 pm IST · Filing received 3 Oct 2026, 07:58 pm IST

What happened

Pashupati Cotspin (PASHUPATI) filed a disclosure with the exchanges on 3 October 2026 at 07:58 PM titled "Board of Directors at its meeting held on October 03, 2026, have considered and approved bonus at the ratio of 236760000 : 157840000, i.e 236760000 Equity Shares for every…".

Company snapshot

Pashupati Cotspin is a small-cap company, with a market value of about ₹1,247 crore.

The stock last traded at ₹78.99, against a 52-week range of ₹67.75–₹118.4 (33.3% below the high).

Before this filing the shares had moved −4.9% over the month and −9.8% over three months. Average daily turnover over the last 20 sessions was about ₹2.52 crore.

Promoters held 65.99% at the end of Q1 FY27; 1.92% of promoter shares were pledged. Foreign institutions owned 12.93% and domestic institutions 0.19%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2611821.26
Q2 FY262404.12.59
Q3 FY261592.61.68
Q4 FY261701.70.11
Q1 FY271307.30.46

What history shows

BCEIE has no earlier bonus issue filing from this company on record since May 2026.

Market-wide, 51 bonus issue filings with an impact score of 50 or more saw an average next-day move of +1.3%, with 55% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • 3 October 2026: Board meeting — Bonus/Other business matters.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.